Cytidine analogs are synthetic lethal with base excision repair default due to MBD4 deficiency.

Bibliographic Details
Title: Cytidine analogs are synthetic lethal with base excision repair default due to MBD4 deficiency.
Authors: Chabot, Thomas, Nemati, Fariba, Herbette, Aurélie, Demeyer, Alexandre, Dayot, Stéphane, Ganier, Olivier, Alsafadi, Samar, Gardrat, Sophie, Mariani, Pascale, Luporsi, Marie, Corbé, Maxime, Servois, Vincent, Cassoux, Nathalie, Decaudin, Didier, Roman, Sergio Roman, Del Nery, Elaine, Piperno-Neumann, Sophie, Stern, Marc-Henri, Rodrigues, Manuel
Source: NPJ Precision Oncology; 11/2/2022, Vol. 6 Issue 1, p1-9, 9p
Subject Terms: DRUG repositioning, UVEA cancer, DEAMINATION, CANCER cells
Abstract: Inactivating mutations of MBD4 have been reported in subsets of various tumors. A deficiency of this DNA glycosylase, recognizing specifically T:G mismatch resulting from the deamination of methyl-cytosine, results in a hypermutated phenotype due to the accumulation of CpG>TpG transitions. Here, we hypothesize that the difference in DNA metabolism consecutive to MBD4 deficiency may result in specific cytotoxicities in MBD4-deficient tumor cells in a synthetic lethality fashion. After a large-scale drug repurposing screen, we show in two isogenic MBD4 knock-out cell models that the inactivation of MBD4 sensitizes cancer cells to cytidine analogs. We further confirm the exquisite activity of gemcitabine in an MBD4-deficient co-clinical model as (i) it completely prevented the development of an MBD4-deficient uveal melanoma patient-derived xenograft and (ii) treatment in the corresponding patient resulted in an exceptional tumor response. These data suggest that patients harboring MBD4-deficient tumors may be treated efficiently by cytidine analogs. [ABSTRACT FROM AUTHOR]
Copyright of NPJ Precision Oncology is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
More Details
ISSN:2397768X
DOI:10.1038/s41698-022-00326-z
Published in:NPJ Precision Oncology
Language:English